Liraglutide Injection Prefilled Pens
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes and support weight loss in adults with obesity or overweight conditions. It works by mimicking a natural hormone that helps regulate blood sugar levels, slows gastric emptying, and reduces appetite. This leads to improved glucose control and gradual weight reduction. Liraglutide is typically injected once daily and may also help lower the risk of cardiovascular events in certain patients with type 2 diabetes and heart disease.
- Liraglutide is a GLP-1 receptor agonist that mimics the incretin hormone to lower blood sugar.
- It is FDA-approved for the treatment of type 2 diabetes under the brand name Victoza.
- It is also approved for chronic weight management under the brand name Saxenda.
- Liraglutide helps increase insulin secretion in response to meals, improving postprandial glucose levels.
- It slows gastric emptying, which promotes a feeling of fullness and reduces appetite.
- Liraglutide is administered as a once-daily subcutaneous injection.
- Liraglutide is supplied in a prefilled pen, but requires the use of disposable pen needles, which are not included and must be purchased separately.
-
Liraglutide Injection Prefilled Pens Side Effects
Liraglutide Injection Prefilled Pens side effects may include the following: The most common side effects are gastrointestinal in nature, such as nausea, vomiting, diarrhea, constipation, and decreased appetite, especially during the initial weeks of treatment. Some patients may also experience abdominal pain, indigestion, or bloating. Headache, fatigue, and dizziness have been reported as well. Less common but more serious side effects include pancreatitis, gallbladder disease, kidney problems, and increased heart rate. In rare cases, liraglutide has been associated with thyroid C-cell tumors, including medullary thyroid carcinoma, which is why it carries a boxed warning. Injection site reactions, such as redness or irritation, may also occur. Patients should be monitored for signs of hypoglycemia if liraglutide is used with other glucose-lowering agents like insulin or sulfonylureas.
-
Consumer Information Use and Disclaimer
This information should not be used to decide whether or not to take this medicine or any other medicine. Only a healthcare provider has the knowledge and training to decide which medicines are right for you. TelyRx does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a limited summary of general information about the medicine’s uses from the patient education materials and is not intended to be comprehensive. This limited summary does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not intended to provide medical advice, diagnosis or treatment and does not replace information you may receive from your healthcare provider. For a more detailed summary of information about the risks and benefits of using this medicine, please review the entire patient education information you receive with the medication.
How TelyRx Works


1. You Choose
Request Your Prescription


2. Doctor Prescribes
We Dispense and Deliver


3. We Deliver
Your Medication Quickly and Discreetly
Verified Customer Reviews
Sex | Both |
---|---|
Pick and Pack | Yes |
Order Flagging System | No |
Robots Meta | INDEX, FOLLOW |